| scholarly article | Q13442814 |
| P50 | author | Lin Leng | Q85637007 |
| Pathricia V Tilstam | Q59663420 | ||
| P2093 | author name string | Richard Bucala | |
| Dake Qi | |||
| Lawrence Young | |||
| P2860 | cites work | Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma | Q79318135 |
| Macrophage migration inhibitory factor: a probable link between inflammation and cancer | Q80003629 | ||
| Macrophage migration inhibitory factor (MIF) and oligoarticular juvenile idiopathic arthritis (o-JIA): association of MIF promoter polymorphisms with response to intra-articular glucocorticoids | Q80195889 | ||
| Evidence for vascular macrophage migration inhibitory factor in destabilization of human atherosclerotic plaques | Q81202695 | ||
| A single nucleotide polymorphism of macrophage migration inhibitory factor is related to inflammatory response in coronary bypass surgery using cardiopulmonary bypass | Q82778825 | ||
| Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: a predominant role of anti-inflammation | Q83152715 | ||
| Cardioprotection through S-nitros(yl)ation of macrophage migration inhibitory factor | Q83638984 | ||
| Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy | Q85412079 | ||
| Increased expression of macrophage migration inhibitory factor in aorta of patients with coronary atherosclerosis | Q95515974 | ||
| MIF signal transduction initiated by binding to CD74 | Q24303802 | ||
| CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex | Q24307384 | ||
| Simultaneous detection of microsatellite repeats and SNPs in the macrophage migration inhibitory factor (MIF) gene by thin-film biosensor chips and application to rural field studies | Q24816150 | ||
| Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion | Q27481089 | ||
| Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 A resolution | Q27617542 | ||
| Coumarin and chromen-4-one analogues as tautomerase inhibitors of macrophage migration inhibitory factor: discovery and X-ray crystallography | Q27629426 | ||
| The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents | Q27638947 | ||
| Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast | Q27662149 | ||
| Targeting distinct tautomerase sites of D-DT and MIF with a single molecule for inhibition of neutrophil lung recruitment | Q27684665 | ||
| Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1 | Q28138425 | ||
| Macrophage migration inhibitory factor: a regulator of innate immunity | Q28204158 | ||
| Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data | Q28242645 | ||
| Isolation of a new tautomerase monitored by the conversion of D-dopachrome to 5,6-dihydroxyindole | Q28257604 | ||
| MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia | Q28265011 | ||
| The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity | Q28295198 | ||
| MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment | Q28298072 | ||
| Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells | Q47858881 | ||
| Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase | Q47885573 | ||
| Phase I, multicentre, dose-escalation trial of monotherapy with milatuzumab (humanized anti-CD74 monoclonal antibody) in relapsed or refractory multiple myeloma | Q50765392 | ||
| Macrophage migration inhibitory factor interacts with thioredoxin-interacting protein and induces NF-κB activity | Q51092500 | ||
| Progress in interventional cardiology: challenges for the future | Q51152036 | ||
| Targeted intracellular accumulation of macrophage migration inhibitory factor in the reperfused heart mediates cardioprotection. | Q53371260 | ||
| Serum macrophage migration inhibitory factor levels are associated with angiographically complex coronary lesions in patients with coronary artery disease | Q53383286 | ||
| Association of macrophage migration inhibitory factor -173C allele polymorphism with steroid resistance in children with nephrotic syndrome. | Q53845656 | ||
| Up-regulation and coexpression of MIF and matrix metalloproteinases in human abdominal aortic aneurysms. | Q54647435 | ||
| Macrophage migration inhibitory factor increases leukocyte-endothelial interactions in human endothelial cells via promotion of expression of adhesion molecules. | Q54667217 | ||
| Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: Results from the MONICA/KORA Augsburg case-cohort study, 1984–2002 | Q57303220 | ||
| A polymorphism in the macrophage migration inhibitory factor gene is involved in the genetic predisposition of Crohn's disease and associated with cumulative steroid doses | Q60689149 | ||
| Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF) | Q63915224 | ||
| Stabilization of Atherosclerotic Plaques by Blockade of Macrophage Migration Inhibitory Factor After Vascular Injury in Apolipoprotein E–Deficient Mice | Q63915243 | ||
| Protection from septic shock by neutralization of macrophage migration inhibitory factor | Q64132865 | ||
| Macrophage Migration Inhibitory Factor Provides Cardioprotection During Ischemia/Reperfusion by Reducing Oxidative Stress | Q64374815 | ||
| Expression of Macrophage Migration Inhibitory Factor in Acute Ischemic Myocardial Injury | Q73293115 | ||
| Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis | Q73316815 | ||
| Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IkappaBalpha | Q74217866 | ||
| A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis | Q74315912 | ||
| Elevation of plasma level of macrophage migration inhibitory factor in patients with acute myocardial infarction | Q74598901 | ||
| Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis | Q77857409 | ||
| Modeling of both shared and distinct interactions between MIF and its homologue D-DT with their common receptor CD74. | Q46669179 | ||
| Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity | Q46669596 | ||
| Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart. | Q46781819 | ||
| Evidence for a role of macrophage migration inhibitory factor in vascular disease | Q47232432 | ||
| Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex | Q28588442 | ||
| Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: Regulatory role in the innate immune response | Q28592426 | ||
| Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action | Q28594433 | ||
| Macrophage Migration Inhibitory Factor Is Enhanced in Acute Coronary Syndromes and Is Associated with the Inflammatory Response | Q28728841 | ||
| Progress and challenges in translating the biology of atherosclerosis | Q29619982 | ||
| The changing face of cardiovascular disease 2000-2012: An analysis of the world health organisation global health estimates data | Q30244192 | ||
| Chronic coronary artery disease: diagnosis and management | Q30492121 | ||
| A nuclease that mediates cell death induced by DNA damage and poly(ADP-ribose) polymerase-1 | Q30830656 | ||
| Identification and characterization of novel classes of macrophage migration inhibitory factor (MIF) inhibitors with distinct mechanisms of action | Q33591955 | ||
| Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites | Q33896841 | ||
| Association between the -794 (CATT)5-8 MIF gene polymorphism and susceptibility to acute coronary syndrome in a western Mexican population. | Q33930320 | ||
| The vestigial enzyme D-dopachrome tautomerase protects the heart against ischemic injury | Q33944140 | ||
| Impaired macrophage migration inhibitory factor-AMP-activated protein kinase activation and ischemic recovery in the senescent heart | Q34009213 | ||
| Optimization of N-benzyl-benzoxazol-2-ones as receptor antagonists of macrophage migration inhibitory factor (MIF) | Q34127116 | ||
| The Action of D-Dopachrome Tautomerase as an Adipokine in Adipocyte Lipid Metabolism | Q34200909 | ||
| Receptor agonists of macrophage migration inhibitory factor | Q34340164 | ||
| RTL therapy for multiple sclerosis: a Phase I clinical study. | Q34520672 | ||
| Myocardial reperfusion injury. | Q34687124 | ||
| Macrophage migration inhibitory factor in cardiovascular disease | Q34764306 | ||
| Differential roles of cardiac and leukocyte derived macrophage migration inhibitory factor in inflammatory responses and cardiac remodelling post myocardial infarction | Q35049835 | ||
| A small-molecule macrophage migration inhibitory factor antagonist protects against glomerulonephritis in lupus-prone NZB/NZW F1 and MRL/lpr mice. | Q35071632 | ||
| The D -dopachrome tautomerase ( DDT ) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF) | Q35180790 | ||
| Macrophage migration inhibitory factor polymorphism is associated with susceptibility to inflammatory coronary heart disease | Q35189344 | ||
| Attenuation of atherosclerotic lesions in diabetic apolipoprotein E-deficient mice using gene silencing of macrophage migration inhibitory factor | Q35391070 | ||
| Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus | Q35585133 | ||
| The macrophage migration inhibitory factor protein superfamily in obesity and wound repair | Q35681520 | ||
| Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo | Q35748894 | ||
| Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression | Q35760817 | ||
| An Analysis of MIF Structural Features that Control Functional Activation of CD74. | Q36075317 | ||
| Interaction of MIF Family Proteins in Myocardial Ischemia/Reperfusion Damage and Their Influence on Clinical Outcome of Cardiac Surgery Patients | Q36191684 | ||
| New insights into the role and mechanism of macrophage migration inhibitory factor in steroid-resistant patients with systemic lupus erythematosus | Q36245929 | ||
| Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases | Q36291764 | ||
| Myocardial ischemia-reperfusion injury: a neglected therapeutic target | Q36497176 | ||
| Transcription factor ICBP90 regulates the MIF promoter and immune susceptibility locus. | Q36515036 | ||
| Macrophage Migration Inhibitory Factor (MIF) Deficiency Exacerbates Aging-Induced Cardiac Remodeling and Dysfunction Despite Improved Inflammation: Role of Autophagy Regulation | Q36650905 | ||
| Small molecular modulation of macrophage migration inhibitory factor in the hyperoxia-induced mouse model of bronchopulmonary dysplasia | Q36797421 | ||
| Structural determinants of MIF functions in CXCR2-mediated inflammatory and atherogenic leukocyte recruitment | Q36935739 | ||
| Relationship between elevated soluble CD74 and severity of experimental and clinical ALI/ARDS | Q37117393 | ||
| Chemokine-like functions of MIF in atherosclerosis | Q37127327 | ||
| Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening | Q37187080 | ||
| Limiting Cardiac Ischemic Injury by Pharmacological Augmentation of Macrophage Migration Inhibitory Factor–AMP-Activated Protein Kinase Signal Transduction | Q37193766 | ||
| Pro-inflammatory action of MIF in acute myocardial infarction via activation of peripheral blood mononuclear cells | Q37209979 | ||
| Plasma Macrophage Migration Inhibitor Factor Is Elevated in Response to Myocardial Ischemia | Q37240620 | ||
| The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia | Q37280809 | ||
| MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease | Q37280881 | ||
| Exogenous Administration of Recombinant MIF at Physiological Concentrations Failed to Attenuate Infarct Size in a Langendorff Perfused Isolated Mouse Heart Model | Q37321912 | ||
| Inflammation and plaque vulnerability | Q37370224 | ||
| The role of macrophage migration inhibitory factor in autoimmune liver disease | Q37423459 | ||
| MIF allele-dependent regulation of the MIF coreceptor CD44 and role in rheumatoid arthritis. | Q37493256 | ||
| D-dopachrome tautomerase in adipose tissue inflammation and wound repair | Q37539870 | ||
| Predicted structure of MIF/CD74 and RTL1000/CD74 complexes | Q37595880 | ||
| Plasma Levels of Macrophage Migration Inhibitory Factor and d-Dopachrome Tautomerase Show a Highly Specific Profile in Early Life | Q37604131 | ||
| MIF Gene Polymorphism rs755622 Is Associated With Coronary Artery Disease and Severity of Coronary Lesions in a Chinese Kazakh Population: A Case-Control Study | Q37624131 | ||
| D-dopachrome tautomerase (D-DT or MIF-2): Doubling the MIF cytokine family | Q38002982 | ||
| Macrophage migration inhibitory factor in myocardial ischaemia/reperfusion injury | Q38199944 | ||
| Role of MIF in myocardial ischaemia and infarction: insight from recent clinical and experimental findings | Q38201763 | ||
| Systemic inflammatory response following acute myocardial infarction | Q38531965 | ||
| AMPK: energy sensor and survival mechanism in the ischemic heart | Q38544724 | ||
| Platelet-derived MIF: a novel platelet chemokine with distinct recruitment properties. | Q38922918 | ||
| d-Dopachrome tautomerase promotes IL-6 expression and inhibits adipogenesis in preadipocytes | Q39285040 | ||
| The clinical significance of the MIF homolog d-dopachrome tautomerase (MIF-2) and its circulating receptor (sCD74) in burn | Q39746527 | ||
| Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion | Q39773528 | ||
| The Golgi-associated protein p115 mediates the secretion of macrophage migration inhibitory factor. | Q39849398 | ||
| Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity | Q40169158 | ||
| Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1. | Q40362124 | ||
| Impact of counterbalance between macrophage migration inhibitory factor and its inhibitor Gremlin-1 in patients with coronary artery disease | Q41739542 | ||
| Molecular Pathways Underlying Cardiac Remodeling During Pathophysiological Stimulation | Q41855920 | ||
| Macrophage migration inhibitory factor deletion exacerbates pressure overload-induced cardiac hypertrophy through mitigating autophagy | Q41967343 | ||
| Macrophage migration inhibitory factor exhibits a pronounced circadian rhythm relevant to its role as a glucocorticoid counter-regulator | Q42438155 | ||
| Structure of a trimeric domain of the MHC class II-associated chaperonin and targeting protein Ii. | Q42661328 | ||
| Compartmentalized protective and detrimental effects of endogenous macrophage migration-inhibitory factor mediated by CXCR2 in a mouse model of myocardial ischemia/reperfusion | Q43159405 | ||
| A tautomerase-null macrophage migration-inhibitory factor (MIF) gene knock-in mouse model reveals that protein interactions and not enzymatic activity mediate MIF-dependent growth regulation | Q43163083 | ||
| Macrophage migration inhibitory factor as a redox-sensitive cytokine in cardiac myocytes | Q43818599 | ||
| The cytokine macrophage migration inhibitory factor reduces pro-oxidative stress-induced apoptosis | Q44355422 | ||
| Association between MIF gene polymorphisms and carotid artery atherosclerosis | Q44492214 | ||
| ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis | Q46663769 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| P304 | page(s) | 671-683 | |
| P577 | publication date | 2017-07-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Expert Opinion on Therapeutic Targets | Q5421214 |
| P1476 | title | MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics | |
| P478 | volume | 21 |
| Q64122506 | Correlation between Plasma Macrophage Migration Inhibitory Factor Levels and Long-Term Prognosis in Patients with Acute Myocardial Infarction Complicated with Diabetes |
| Q90283492 | Cross-Kingdom Analysis of Diversity, Evolutionary History, and Site Selection within the Eukaryotic Macrophage Migration Inhibitory Factor Superfamily |
| Q90189697 | Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets? |
| Q100526128 | Genetic regulation of gene expression of MIF family members in lung tissue |
| Q51734324 | Identification of an Arg-Leu-Arg tripeptide that contributes to the binding interface between the cytokine MIF and the chemokine receptor CXCR4. |
| Q64245639 | Macrophage Migration Inhibitory Factor (MIF) Expression Increases during Myocardial Infarction and Supports Pro-Inflammatory Signaling in Cardiac Fibroblasts |
| Q91026071 | Macrophage migration inhibitory factor increases atrial arrhythmogenesis through CD74 signaling |
| Q52699530 | Novel half-life extended anti-MIF nanobodies protect against endotoxic shock. |
| Q64933431 | Porphyromonas gingivalis-Induced MIF Regulates Intercellular Adhesion Molecule-1 Expression in EA.hy926 Cells and Monocyte-Endothelial Cell Adhesion Through the Receptors CD74 and CXCR4. |
| Q99549217 | The Macrophage Migration Inhibitory Factor (MIF) Promoter Polymorphisms (rs3063368, rs755622) Predict Acute Kidney Injury and Death after Cardiac Surgery |
| Q61811076 | The Multitasking Potential of Alarmins and Atypical Chemokines |
| Q53699115 | The Role of Cardiokines in Heart Diseases: Beneficial or Detrimental? |
| Q92637631 | The Role of Macrophage Migration Inhibitory Factor in Alzheimer's Disease: Conventionally Pathogenetic or Unconventionally Protective? |
Search more.